Global and United States Cetuximab Market Report & Forecast 2023-2028

Report ID: 1830336 | Published Date: Sep 2024 | No. of Page: 70 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
1 Study Coverage
    1.1 Cetuximab Product Introduction
    1.2 Global Cetuximab Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cetuximab Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Cetuximab Sales in Volume for the Year 2017-2028
    1.3 United States Cetuximab Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Cetuximab Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Cetuximab Sales in Volume for the Year 2017-2028
    1.4 Cetuximab Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Cetuximab in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Cetuximab Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Cetuximab Market Dynamics
        1.5.1 Cetuximab Industry Trends
        1.5.2 Cetuximab Market Drivers
        1.5.3 Cetuximab Market Challenges
        1.5.4 Cetuximab Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Cetuximab Market Segment by Type
        2.1.1 100 mg/50 mL Injection
        2.1.2 200 mg/100 mL Injection
    2.2 Global Cetuximab Market Size by Type
        2.2.1 Global Cetuximab Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Cetuximab Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Cetuximab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Cetuximab Market Size by Type
        2.3.1 United States Cetuximab Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Cetuximab Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Cetuximab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Cetuximab Market Segment by Application
        3.1.1 Head and Neck Cancer
        3.1.2 Metastatic Colorectal Cancer
    3.2 Global Cetuximab Market Size by Application
        3.2.1 Global Cetuximab Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Cetuximab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Cetuximab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Cetuximab Market Size by Application
        3.3.1 United States Cetuximab Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Cetuximab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Cetuximab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Cetuximab Competitor Landscape by Company
    4.1 Global Cetuximab Market Size by Company
        4.1.1 Top Global Cetuximab Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Cetuximab Revenue by Manufacturer (2017-2022)
        4.1.3 Global Cetuximab Sales by Manufacturer (2017-2022)
        4.1.4 Global Cetuximab Price by Manufacturer (2017-2022)
    4.2 Global Cetuximab Concentration Ratio (CR)
        4.2.1 Cetuximab Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cetuximab in 2021
        4.2.3 Global Cetuximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cetuximab Manufacturing Base Distribution, Product Type
        4.3.1 Global Cetuximab Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Cetuximab Product Type
        4.3.3 Date of International Manufacturers Enter into Cetuximab Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Cetuximab Market Size by Company
        4.5.1 Top Cetuximab Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cetuximab Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Cetuximab Sales by Players (2020, 2021 & 2022)
5 Global Cetuximab Market Size by Region
    5.1 Global Cetuximab Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cetuximab Market Size in Volume by Region (2017-2028)
        5.2.1 Global Cetuximab Sales in Volume by Region: 2017-2022
        5.2.2 Global Cetuximab Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Cetuximab Market Size in Value by Region (2017-2028)
        5.3.1 Global Cetuximab Sales in Value by Region: 2017-2022
        5.3.2 Global Cetuximab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cetuximab Market Size YoY Growth 2017-2028
        6.1.2 North America Cetuximab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cetuximab Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cetuximab Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cetuximab Market Size YoY Growth 2017-2028
        6.3.2 Europe Cetuximab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cetuximab Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cetuximab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cetuximab Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cetuximab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Corporation Information
        7.1.2 Eli Lilly Description and Business Overview
        7.1.3 Eli Lilly Cetuximab Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Eli Lilly Cetuximab Products Offered
        7.1.5 Eli Lilly Recent Development
    7.2 Merck
        7.2.1 Merck Corporation Information
        7.2.2 Merck Description and Business Overview
        7.2.3 Merck Cetuximab Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Merck Cetuximab Products Offered
        7.2.5 Merck Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Cetuximab Industry Chain Analysis
    8.2 Cetuximab Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Cetuximab Distributors
    8.3 Cetuximab Production Mode & Process
    8.4 Cetuximab Sales and Marketing
        8.4.1 Cetuximab Sales Channels
        8.4.2 Cetuximab Distributors
    8.5 Cetuximab Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Cetuximab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Cetuximab Market Trends
    Table 3. Cetuximab Market Drivers
    Table 4. Cetuximab Market Challenges
    Table 5. Cetuximab Market Restraints
    Table 6. Global Cetuximab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cetuximab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cetuximab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cetuximab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cetuximab Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cetuximab Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Cetuximab Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Cetuximab Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Cetuximab Sales Share by Manufacturer, 2017-2022
    Table 15. Global Cetuximab Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Cetuximab Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Cetuximab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cetuximab as of 2021)
    Table 18. Top Players of Cetuximab in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Cetuximab Product Type
    Table 20. Date of International Manufacturers Enter into Cetuximab Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Cetuximab Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Cetuximab Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Cetuximab Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Cetuximab Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Cetuximab Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Cetuximab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Cetuximab Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Cetuximab Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Cetuximab Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Cetuximab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Cetuximab Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Cetuximab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Cetuximab Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Cetuximab Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Cetuximab Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Cetuximab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Cetuximab Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Cetuximab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Cetuximab Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Cetuximab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eli Lilly Corporation Information
    Table 43. Eli Lilly Description and Business Overview
    Table 44. Eli Lilly Cetuximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Eli Lilly Cetuximab Product
    Table 46. Eli Lilly Recent Development
    Table 47. Merck Corporation Information
    Table 48. Merck Description and Business Overview
    Table 49. Merck Cetuximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Merck Product
    Table 51. Merck Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Cetuximab Customers List
    Table 55. Cetuximab Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cetuximab Product Picture
    Figure 2. Global Cetuximab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cetuximab Market Size 2017-2028 (US$ Million)
    Figure 4. Global Cetuximab Sales 2017-2028 (K Units)
    Figure 5. United States Cetuximab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Cetuximab Market Size 2017-2028 (US$ Million)
    Figure 7. United States Cetuximab Sales 2017-2028 (K Units)
    Figure 8. United States Cetuximab Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Cetuximab Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Cetuximab Report Years Considered
    Figure 11. Product Picture of 100 mg/50 mL Injection
    Figure 12. Product Picture of 200 mg/100 mL Injection
    Figure 13. Global Cetuximab Market Share by Type in 2022 & 2028
    Figure 14. Global Cetuximab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Cetuximab Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Cetuximab Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Cetuximab Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Cetuximab Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Cetuximab Market Share by Type in 2022 & 2028
    Figure 20. United States Cetuximab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Cetuximab Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Cetuximab Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Cetuximab Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Cetuximab Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Head and Neck Cancer
    Figure 26. Product Picture of Metastatic Colorectal Cancer
    Figure 27. Global Cetuximab Market Share by Application in 2022 & 2028
    Figure 28. Global Cetuximab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Cetuximab Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Cetuximab Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Cetuximab Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Cetuximab Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Cetuximab Market Share by Application in 2022 & 2028
    Figure 34. United States Cetuximab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Cetuximab Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Cetuximab Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Cetuximab Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Cetuximab Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Cetuximab Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Cetuximab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Cetuximab Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Cetuximab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Cetuximab Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Cetuximab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Cetuximab Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Cetuximab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Cetuximab Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Cetuximab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Cetuximab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Cetuximab Value Chain
    Figure 73. Cetuximab Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Merck
Frequently Asked Questions
Cetuximab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cetuximab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cetuximab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Azacitidine Drug

Azacitidine Drug market is segmented by region (country), players, by Type and by Application. Pl ... Read More

Rifaximin

Rifaximin market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Trospium Chloride

Trospium Chloride market is segmented by region (country), players, by Type and by Application. P ... Read More

Cinacalcet

Cinacalcet market is segmented by region (country), players, by Type and by Application. Players, ... Read More